magstim Archives - Medical Design Sourcing

MagStim wins FDA nod for latest transcranial magnetic stim tech

The Horizon 3.0 TMS system with StimGuide Pro. [Image courtesy of Magstim]Magstim announced today that it received FDA clearance for its Horizon 3.0 transcranial magnetic stimulation (TMS) system with StimGuide Pro.

The latest platform builds on the previous H 3.0 system for treating patients with depressive or obsessive-compulsive conditions.

Horizon 3.0 with StimGuie Pro is the first integrated TMS system with navigation, Magstim said in a news release. It includes new advanced camera technology and software designed to allow for precise treatment targeting.

The system centralizes all patient treatments and technology on one screen to reduce complexity as well. It also has a Bluetooth anatomical pointer for mapping and treating patients.

Non-invasive TMS uses an electromagnetic coil to stimulate nerve cells in the brain region involved in mood control and depression. StimGuide Pro’s advanced navigation improves coil positioning for repeatabil…

FDA clears Magstim advanced transcranial magnetic stimulation platform

[Image from Magstim]

Magstim announced today that it received FDA 510(k) clearance for its Horizon 3.0 transcranial magnetic stimulation platform.

Horizon 3.0 offers enhanced workflows with navigated transcranial magnetic stimulation (TMS) and analytics for the clinical setting, offering connected care at networked sites, according to a news release.

Get the full story at our sister site, MassDevice.

FDA clears Magstim advanced transcranial magnetic stimulation platform

[Image from Magstim]Magstim announced today that it received FDA 510(k) clearance for its Horizon 3.0 transcranial magnetic stimulation platform.

Horizon 3.0 offers enhanced workflows with navigated transcranial magnetic stimulation (TMS) and analytics for the clinical setting, offering connected care at networked sites, according to a news release.

TMS, a form of non-invasive brain stimulation, uses an electromagnetic coil to stimulate nerve cells in the region of the brain involved in mood control and depression.

Magstim’s Horizon 3.0 platform combines its StimGuide+ to add new layers of quality control analytics and workflow improvements to the first FDA-cleared TMS navigation system designed for the clinical setting, Magstim said.

“We spoke with physicians, patients, researchers and employees and asked them to imagine the next generation of TMS technology,” Magstim CEO Lothar Krinke said in the release. “How can we improve patient care effi…

Neurosign launches new intraoperative nerve monitor to preserve nerves

[Neurosign V4 image courtesy of WVU/Brian Persinger]Neurosign today announced the U.S. launch of its V4 system for monitoring cranial nerves and spinal nerve roots during surgeries.

FDA cleared the V4 4-channel and 8-channel nerve monitoring system in March.

“We have many years of experience listening to surgeons and developing systems that solve challenges. The V4 is the next iteration of advanced nerve monitoring that focuses on patient safety and preserving the patient’s critical nerve structures,” said Lothar Krinke, CEO of Neurosign’s parent company Welcony (Whitland, U.K.).

Dr. Jeffson Chung of West Virginia University Hospital recently used the V4 in successful thyroidectomy and facial nerve surgeries. He also used the Neurosign Bipolar probe for nerve identification and stimulation. He described neuromonitoring as an additional tool to minimize risk.

The V4 launch comes at the same time that Welcony is finishing work on a new off…

Magstim acquires high-density EEG tech from Philips

Neuroscience researchers worldwide use EGI’s Geodesic Sensor Net (GSN). [Image courtesy of Magstim]

Transcranial magnetic stimulation tech developer Magstim recently announced that it has purchased the product portfolio of Electrical Geodesics from Royal Philips (NYSE:PHG).

Financial terms of the deal were not disclosed.

Magstim will acquire EGI’s hardware, software and sensor nets assets and will immediately manage global sales, service and support, maintaining a presence in EGI’s Oregon office. The deal includes Philips supporting the transition through the end of 2020.

“This adds high-density EEG to our product portfolio supporting more than 1,200 research labs and clinics that focus on mental health, brain disorders and cognitive neuroscience,” said Lothar Krinke, CEO for Magstim, which is based in Whitland, U.K., and has U.S. head…